These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway. Hawkes WC; Alkan Z J Biol Chem; 2012 Aug; 287(33):27371-9. PubMed ID: 22730327 [TBL] [Abstract][Full Text] [Related]
6. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line. Nishimura Y; Takiguchi S; Ito S; Itoh K Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196 [TBL] [Abstract][Full Text] [Related]
7. Pioglitazone inhibits EGFR/MDM2 signaling-mediated PPARγ degradation. Shi J; Zhang W; You M; Xu Y; Hou Y; Jin J Eur J Pharmacol; 2016 Nov; 791():316-321. PubMed ID: 27614128 [TBL] [Abstract][Full Text] [Related]
8. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related]
9. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation. LeVea CM; Reeder JE; Mooney RA Exp Cell Res; 2004 Jul; 297(1):272-84. PubMed ID: 15194442 [TBL] [Abstract][Full Text] [Related]
10. Delayed cell cycle progression from SEPW1 depletion is p53- and p21-dependent in MCF-7 breast cancer cells. Hawkes WC; Alkan Z Biochem Biophys Res Commun; 2011 Sep; 413(1):36-40. PubMed ID: 21875573 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904 [TBL] [Abstract][Full Text] [Related]
12. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913 [TBL] [Abstract][Full Text] [Related]
13. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively. Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581 [TBL] [Abstract][Full Text] [Related]
14. The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor. Jin L; Craven RJ Oncogene; 2014 Jan; 33(3):326-35. PubMed ID: 23318459 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells. Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646 [TBL] [Abstract][Full Text] [Related]
16. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells. Itoh N; Patel U; Skinner MK Endocrinology; 1998 Mar; 139(3):1369-77. PubMed ID: 9492074 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation. Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613 [TBL] [Abstract][Full Text] [Related]
18. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992 [TBL] [Abstract][Full Text] [Related]
19. Methods to study endocytic trafficking of the EGF receptor. Pinilla-Macua I; Sorkin A Methods Cell Biol; 2015; 130():347-67. PubMed ID: 26360045 [TBL] [Abstract][Full Text] [Related]
20. Sulindac metabolites induce proteosomal and lysosomal degradation of the epidermal growth factor receptor. Pangburn HA; Ahnen DJ; Rice PL Cancer Prev Res (Phila); 2010 Apr; 3(4):560-72. PubMed ID: 20332299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]